Verastem, Inc. (VSTM)
9.995
-0.12
(-1.24%)
USD |
NASDAQ |
Dec 10, 16:00
9.995
0.00 (0.00%)
After-Hours: 20:00
Verastem Cash from Investing (Quarterly): -8.279M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CorMedix, Inc. | -291.32M |
| Anavex Life Sciences Corp. | 0.00 |
| Ocugen, Inc. | -0.086M |
| Syndax Pharmaceuticals, Inc. | 72.43M |
| AnaptysBio, Inc. | 103.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -36.22M |
| Cash from Financing (Quarterly) | 17.88M |
| Free Cash Flow | -140.93M |
| Free Cash Flow Per Share (Quarterly) | -0.6082 |
| Free Cash Flow to Equity (Quarterly) | -49.26M |
| Free Cash Flow to Firm (Quarterly) | -44.18M |
| Free Cash Flow Yield | -22.55% |